Madrigal Pharmaceuticals IncNASDAQ:MDGL
- LAST PRICE252.7400
- TODAY'S CHANGE (%)4.0600 (1.6326%)
- Bid / Lots245.0000/ 3
- Ask / Lots260.5000/ 1
- Open / Previous Close247.5000 / 248.6800
- Day Range
- 52 Week Range
- Volume160,168
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MDGL |
|---|---|---|
| 09:32 ET | 3362 | 247.5 |
| 09:34 ET | 3714 | 248.67 |
| 09:52 ET | 250 | 248.43 |
| 09:54 ET | 386 | 247.925 |
| 09:56 ET | 375 | 248.7195 |
| 09:59 ET | 100 | 247.92 |
| 10:01 ET | 300 | 249.03 |
| 10:03 ET | 1400 | 250.895 |
| 10:06 ET | 230 | 251.03 |
| 10:08 ET | 614 | 251.3875 |
| 10:10 ET | 200 | 250.885 |
| 10:12 ET | 800 | 251.25 |
| 10:14 ET | 2081 | 252 |
| 10:15 ET | 100 | 252.495 |
| 10:19 ET | 591 | 251.735 |
| 10:24 ET | 200 | 251.39 |
| 10:26 ET | 100 | 251.91 |
| 10:32 ET | 200 | 253.04 |
| 10:37 ET | 119 | 253.433 |
| 10:39 ET | 100 | 252.905 |
| 10:42 ET | 100 | 252.18 |
| 10:46 ET | 100 | 252.75 |
| 10:48 ET | 250 | 253 |
| 10:50 ET | 1200 | 250.8971 |
| 10:51 ET | 200 | 251.405 |
| 10:53 ET | 403 | 251.78 |
| 10:55 ET | 100 | 250.6 |
| 10:57 ET | 700 | 251.3 |
| 11:00 ET | 300 | 252.16 |
| 11:02 ET | 100 | 252.95 |
| 11:04 ET | 100 | 252.04 |
| 11:06 ET | 362 | 252.9 |
| 11:08 ET | 1672 | 253 |
| 11:09 ET | 100 | 252.58 |
| 11:20 ET | 100 | 251.96 |
| 11:22 ET | 100 | 252.38 |
| 11:26 ET | 100 | 251.76 |
| 11:27 ET | 300 | 252.5528 |
| 11:33 ET | 100 | 252.16 |
| 11:40 ET | 907 | 252.225 |
| 11:42 ET | 100 | 252.48 |
| 11:45 ET | 496 | 252.4 |
| 11:47 ET | 425 | 252.15 |
| 11:49 ET | 100 | 251.9 |
| 11:54 ET | 100 | 251.94 |
| 12:02 ET | 300 | 250.4 |
| 12:03 ET | 100 | 250.495 |
| 12:05 ET | 100 | 251.14 |
| 12:21 ET | 250 | 252 |
| 12:23 ET | 1517 | 251.165 |
| 12:25 ET | 200 | 251.8 |
| 12:41 ET | 200 | 252 |
| 12:43 ET | 830 | 251.5 |
| 12:45 ET | 100 | 251.44 |
| 12:52 ET | 125 | 251.3705 |
| 12:54 ET | 2000 | 251.61 |
| 12:59 ET | 2071 | 252.21 |
| 01:03 ET | 200 | 252.21 |
| 01:08 ET | 600 | 252.6 |
| 01:12 ET | 300 | 252.18 |
| 01:14 ET | 528 | 252.215 |
| 01:21 ET | 200 | 252.18 |
| 01:24 ET | 100 | 251.94 |
| 01:28 ET | 200 | 252.38 |
| 01:30 ET | 100 | 252.4 |
| 01:39 ET | 100 | 252.69 |
| 01:44 ET | 200 | 253.25 |
| 01:46 ET | 100 | 253.05 |
| 01:48 ET | 259 | 253.12 |
| 01:50 ET | 100 | 253.39 |
| 01:55 ET | 600 | 253.695 |
| 02:00 ET | 800 | 253.695 |
| 02:04 ET | 996 | 253.54 |
| 02:08 ET | 2621 | 252.91 |
| 02:09 ET | 200 | 253.455 |
| 02:18 ET | 100 | 253.52 |
| 02:24 ET | 100 | 253.29 |
| 02:26 ET | 2016 | 253.35 |
| 02:31 ET | 100 | 252.08 |
| 02:36 ET | 100 | 252.09 |
| 02:42 ET | 148 | 252.56 |
| 03:00 ET | 100 | 251.17 |
| 03:02 ET | 100 | 251.17 |
| 03:03 ET | 600 | 251.06 |
| 03:05 ET | 100 | 250.71 |
| 03:07 ET | 100 | 250.52 |
| 03:09 ET | 182 | 250.86 |
| 03:14 ET | 617 | 251.31 |
| 03:20 ET | 100 | 252.12 |
| 03:21 ET | 700 | 252.11 |
| 03:27 ET | 1137 | 252.5 |
| 03:30 ET | 200 | 252.765 |
| 03:32 ET | 100 | 252.59 |
| 03:34 ET | 100 | 252.54 |
| 03:36 ET | 100 | 252.59 |
| 03:38 ET | 400 | 252.19 |
| 03:41 ET | 200 | 252.04 |
| 03:43 ET | 100 | 252.66 |
| 03:45 ET | 113 | 252.47 |
| 03:48 ET | 300 | 252.24 |
| 03:50 ET | 400 | 252.6235 |
| 03:52 ET | 500 | 252.33 |
| 03:54 ET | 200 | 253 |
| 03:56 ET | 6385 | 253 |
| 03:57 ET | 721 | 252.43 |
| 03:59 ET | 27673 | 252.74 |
Aug 8, 2024
DJ Madrigal Pharmaceuticals Is Maintained at Buy by Citigroup, from 3:32PM ET on Thursday Aug 08, 2024 by Dow Jones
3:32PM ET on Thursday Aug 08, 2024 by Dow JonesDJ Madrigal Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group, from 9:19AM ET on Thursday Aug 08, 2024 by Dow Jones
9:19AM ET on Thursday Aug 08, 2024 by Dow Jones
Aug 7, 2024
*DJ Madrigal Pharmaceuticals 2Q Loss/Shr $7.10 >MDGL, from 7:00AM ET on Wednesday Aug 07, 2024 by Dow Jones
7:00AM ET on Wednesday Aug 07, 2024 by Dow JonesMadrigal Pharmaceuticals Reports Second-Quarter 2024 Financial Results and Provides Corporate Updates, from 7:00AM ET on Wednesday Aug 07, 2024 by Dow Jones
7:00AM ET on Wednesday Aug 07, 2024 by Dow Jones
Aug 2, 2024
Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel, from 7:00AM ET on Friday Aug 02, 2024 by Dow Jones
7:00AM ET on Friday Aug 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Madrigal Pharmaceuticals Inc | 5.4B | -9.9x | --- |
Nuvalent Inc | 5.4B | -30.7x | --- |
Avidity Biosciences Inc | 5.0B | -14.7x | --- |
Krystal Biotech Inc | 5.7B | 55.2x | --- |
BridgeBio Pharma Inc | 4.7B | -9.6x | --- |
Immunovant Inc | 4.6B | -16.9x | --- |
Company Information
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.
Contact Information
- Headquarters
- 200 Barr Harbor Dr Ste 400WEST CONSHOHOCKEN, PA, United States 19428-2978
- Phone
- 404-380-9263
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Julian Baker
- President, Chief Executive Officer, Director
- Bill Sibold
- Chief Financial Officer, Senior Vice President
- Mardi Dier
- President of Research and Development, Chief Medical Officer, Director
- Rebecca Taub
- General Counsel
- Shannon Kelley
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.4B |
|---|---|
Revenue (TTM) | $14.6M |
Shares Outstanding | 21.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.42 |
EPS | $-25.50 |
Book Value | $20.39 |
P/E Ratio | -9.9x |
Price/Sales (TTM) | 368.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,622.65% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
